Tazarotene
Showing 1 - 25 of 74
Scalp Psoriasis Trial in Karachi (Tazarotene 0.045% Topical Application Lotion [ARAZLO])
Completed
- Scalp Psoriasis
- Tazarotene 0.045% Topical Application Lotion [ARAZLO]
-
Karachi, Sindh, PakistanJPMC
Aug 28, 2023
Psoriasis Vulgaris Trial in High Point (0.01% Halobetasol, 0.045% Tazarotene, 0.05% Clobetasol Propionate)
Active, not recruiting
- Psoriasis Vulgaris
- 0.01% Halobetasol
- +2 more
-
High Point, North CarolinaDermatology Consulting Services, PLLC
Sep 16, 2023
Solid Tumor, Hand-Foot Skin Reaction (HFSR) Trial in Boston (Topical Tazarotene, Placebo)
Terminated
- Solid Tumor
- Hand-Foot Skin Reaction (HFSR)
- Topical Tazarotene
- Placebo
-
Boston, MassachusettsDana Farber Cancer Institute
Dec 5, 2022
Scalp Psoriasis Trial in High Point (0.045% Tazarotene/0.01% Halobetasol Lotion)
Recruiting
- Scalp Psoriasis
- 0.045% Tazarotene/0.01% Halobetasol Lotion
-
High Point, North CarolinaDermatology Consulting Services, PLLC
May 14, 2023
Acne Vulgaris, Post Inflammatory Hyperpigmentation, Post Inflammatory Pigmentation Change Trial in Boston (Tazarotene 0.045%
Completed
- Acne Vulgaris
- +4 more
- Tazarotene 0.045% Lotion
-
Boston, MassachusettsThe Dermatology Institute of Boston
Jan 19, 2023
Acne Scar Trial in Karachi (Tazarotene gel 0.1%, Microneedling)
Completed
- Acne Scar
- Tazarotene gel 0.1%
- Microneedling
-
Karachi, Sindh, PakistanJinnah Post graduate medical center
Oct 11, 2022
Warts Flat Trial in Zagazig (Tazarotene 0.1% Gel,Top, Imiquimod, Fluorouracil Cream)
Recruiting
- Warts Flat
- Tazarotene 0.1% Gel,Top
- +3 more
-
Zagazig, Select Region, EgyptDermatology department, Zagazig University Hospitals, Faculty of
May 12, 2022
Plaque Psoriasis Trial in Charlotte (Halobetasol Propionate and Tazarotene Lotion 0.01%/0.045%, Duobrii® Lotion (Halobetasol
Completed
- Plaque Psoriasis
- Halobetasol Propionate and Tazarotene Lotion 0.01%/0.045%
- +2 more
-
Charlotte, North CarolinaCatawba Research, LLC
Mar 15, 2022
Psoriasis Trial (308nm Excimer laser, Tazarotene Topical Gel, Betamethasone Valerate)
Not yet recruiting
- Psoriasis
- 308nm Excimer laser
- +2 more
- (no location specified)
Oct 15, 2022
Acne Keloidalis Nuchae, AKN Trial in New York (Duobrii, Placebo, Bryhali)
Recruiting
- Acne Keloidalis Nuchae
- AKN
- Duobrii
- +2 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Nov 1, 2022
Acne Vulgaris Trial in United States (Adapalene Gel, 0.1%, Tazarotene Cream, 0.1%, Adapalene Gel, 0.1% + Tazarotene Cream, 0.1%)
Completed
- Acne Vulgaris
- Adapalene Gel, 0.1%
- +2 more
-
San Diego, California
- +11 more
Jul 28, 2022
Palmoplantar Psoriasis, Plaque Psoriasis Trial in New York (Duobrii®)
Recruiting
- Palmoplantar Psoriasis
- Plaque Psoriasis
-
New York, New YorkMount Sinai Downtown Union Square
Apr 19, 2021
Acne Vulgaris Trial in Austin (Tazarotene Lotion, 0.1%, Tazarotene Cream, 0.1%)
Completed
- Acne Vulgaris
- Tazarotene Lotion, 0.1%
- Tazarotene Cream, 0.1%
-
Austin, Texas
- +1 more
Feb 4, 2021
Acne Vulgaris Trial in Fremont (DFD-03 (0.1% tazarotene) Lotion, DFD-03 (0% tazarotene) Lotion (Placebo))
Completed
- Acne Vulgaris
- DFD-03 (0.1% tazarotene) Lotion
- DFD-03 (0% tazarotene) Lotion (Placebo)
-
Fremont, CaliforniaCenter for Dermatology Clinical Research Inc.
Feb 4, 2021
Acne Vulgaris Trial in Miami (DFD-03 Lotion, 0.1%, Tazorac Cream, 0.1%, DFD-03 Vehicle Lotion 0%)
Completed
- Acne Vulgaris
- DFD-03 Lotion, 0.1%
- +3 more
-
Miami, FloridaInternational Dermatology Inc.
Aug 13, 2020
Acne Vulgaris Trial in Belize, United States (Tazarotene (Fabior™), Tazarotene (Actavis), Vehicle foam)
Completed
- Acne Vulgaris
- Tazarotene (Fabior™)
- +2 more
-
Encino, California
- +14 more
May 29, 2020
Acne Vulgaris Trial in United States (IDP-123 Lotion, Tazorac Cream, Vehicle Lotion)
Completed
- Acne Vulgaris
- IDP-123 Lotion
- +3 more
-
Encinitas, California
- +15 more
Sep 3, 2020
Acne Vulgaris Trial in United States (CD5789 25 µg/g cream, CD5789 50 µg/g cream, CD5789 100 µg/g cream)
Completed
- Acne Vulgaris
- CD5789 25 µg/g cream
- +4 more
-
Birmingham, Alabama
- +23 more
Aug 23, 2021
Sun-Damaged Skin, Retinoid Intolerance Trial in Ann Arbor (Tazorac, Dove Mild Cleanser, Dove Facial Moisturizer)
Completed
- Sun-Damaged Skin
- Retinoid Intolerance
- Tazorac
- +2 more
-
Ann Arbor, MichiganUniversity of Michigan Department of Dermatology
Mar 11, 2020
Psoriasis Trial in Salt Lake City (Acitretin 25Mg Oral Capsule, Excimer laser, Tazarotene 0.1% Gel,Top)
Terminated
- Psoriasis
- Acitretin 25Mg Oral Capsule
- +3 more
-
Salt Lake City, UtahUniversity of Utah Department of Dermatology
Jun 6, 2019
Acne Vulgaris Trial in Dripping Springs, Pflugerville (Isotretinoin, Amzeeq 4% Topical Foam)
Active, not recruiting
- Acne Vulgaris
- Isotretinoin
- Amzeeq 4% Topical Foam
-
Dripping Springs, Texas
- +1 more
Mar 22, 2022
Keratosis Pilaris Trial in Dayton (Salkera Emollient Foam)
Terminated
- Keratosis Pilaris
- Salkera Emollient Foam
-
Dayton, OhioWright State University School of Medicine, Department of Dermat
Feb 3, 2022